form8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549
_____________________________________________________________________

 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
______________________________________________________________________
 
Date of Report (Date of earliest event reported):  May 4, 2011
 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
 
DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
   
 
One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

 
Registrant's telephone number, including area code:   (508) 650-8000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 
 

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
(b)    On May 4, 2011, J. Raymond Elliott notified our Board of Directors of his intention to retire as President and Chief Executive Officer of the Company effective December 31, 2011.  Mr. Elliott will remain on the Company’s Board of Directors after his retirement.  The Board of Directors has created a special CEO search committee, which includes Mr. Elliott and has commenced its efforts to search for Mr. Elliott’s successor.

A copy of our press release announcing Mr. Elliott’s intention to retire as President and Chief Executive Officer of the Company effective December 31, 2011 is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01   Financial Statements and Exhibits.

(d)           Exhibits

Exhibit No.         Description

99.1                      Press Release dated May 10, 2011.


 
 

 
 

SIGNATURE

 
Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
BOSTON SCIENTIFIC CORPORATION
   
   
   
Date:   May 10, 2011
By: /s/ Timothy A. Pratt
 
Timothy A. Pratt
 
Executive Vice President, Chief Administrative Officer, General Counsel and Secretary


 

 
 

 
 

INDEX TO EXHIBITS

Exhibit No.         Description

99.1                      Press Release dated May 10, 2011.